Screener
Revolution Medicines, Inc. RVMD Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Change in fair value of warrant liability | 166,819 | 2,139 |
| Non-cash interest expense on liabilities related to sale of future royalties | 35,096 | 866 |
| Non-cash interest expense on convertible senior notes | 880 | — |
| Net amortization of premium or discount on marketable securities | (7,556) | (17,560) |
| Amortization of operating lease right-of-use asset | 4,240 | 3,534 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | (41,011) | (935) |
| Accounts payable | 21,888 | 491 |
Item 1. Financial Statements.
FAQ
- What is Revolution Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Revolution Medicines, Inc. (RVMD) reported accretion (amortization) of discounts and premiums, investments of $4.33M in Q2 2026.
- How has Revolution Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Revolution Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 44.0% year-over-year, from $7.74M to $4.33M.
- What is the long-term trend for Revolution Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 74.3% compound annual growth rate (CAGR), from -$3.01M to $27.83M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This reflects the systematic adjustment of the carrying value of investment securities toward their par value over time. It represents the non-cash recognition of interest income or expense derived from the difference between the purchase price and the face value of debt instruments. This metric helps analysts understand the underlying yield and interest-related earnings generated by the company's investment portfolio.
Ask your AI about Revolution Medicines, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude